Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Clinical trial NCT02917772 · COMPLETED

Trial details

NCT number: NCT02917772
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Clear-cell Metastatic Renal Cell Carcinoma

Start date: 2016-10-01
Primary completion: 2021-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.